Cargando…

Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis

BACKGROUND: Head and neck mucosal melanoma (HNMM) is defined as a rare malignant tumor derived from melanocytes. There is no consensus regarding the treatment protocol for HNMM in elderly patients. METHODS: The National Cancer Institute’s Surveillance, Epidemiology, and End Results database was used...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Enni, Wu, Jiawei, Liu, Zhiqiao, Yang, Shanshan, Wu, Jiali, Ouyang, Puyun, Xie, Fangyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033355/
https://www.ncbi.nlm.nih.gov/pubmed/33842612
http://dx.doi.org/10.21037/atm-20-6021
_version_ 1783676396446416896
author Chen, Enni
Wu, Jiawei
Liu, Zhiqiao
Yang, Shanshan
Wu, Jiali
Ouyang, Puyun
Xie, Fangyun
author_facet Chen, Enni
Wu, Jiawei
Liu, Zhiqiao
Yang, Shanshan
Wu, Jiali
Ouyang, Puyun
Xie, Fangyun
author_sort Chen, Enni
collection PubMed
description BACKGROUND: Head and neck mucosal melanoma (HNMM) is defined as a rare malignant tumor derived from melanocytes. There is no consensus regarding the treatment protocol for HNMM in elderly patients. METHODS: The National Cancer Institute’s Surveillance, Epidemiology, and End Results database was used to identify elderly patients diagnosed with HNMM from 1975 to 2016. The chi-squared test was used to compare patient characteristics. The reverse Kaplan-Meier method was used to estimate the median follow-up time. The Kaplan-Meier method and log-rank test were used to estimate and compare the overall survival (OS) and disease-specific survival (DSS) of the groups. Cox regression analysis was used to evaluate the risk factors for OS and DSS of HNMM. RESULTS: Our retrospective study included 828 elderly patients with HNMM, and the 5-year OS and DSS rates were 22.4% and 27.4%, respectively. After adjusting for other variables in multivariate analysis, patients undergoing radiotherapy alone had worse OS [hazard ratio (HR) =1.449, 95% confidence interval (CI): 1.010–1.742, P=0.006] and DSS (HR =1.656, 95% CI: 1.257–2.181, P<0.001) than those undergoing surgery alone. No significant difference in OS (HR =0.892, 95% CI: 0.753–1.056, P=0.183) or DSS (HR =0.917, 95% CI: 0.764–1.101, P=0.354) was observed for patients undergoing surgery with or without radiotherapy. Our analysis of the subgroup of patients with complete clinical staging information demonstrated that the effects of surgery alone on OS (HR =0.734, 95% CI: 0.562–0.958, P=0.023) were inferior to those of surgery with radiotherapy, but no significant difference was noted compared with radiotherapy alone. CONCLUSIONS: The survival of elderly patients with HNMM is increased with the combination of surgery and radiotherapy compared with surgery alone and radiotherapy alone. In addition, the population-based analysis demonstrated that combination therapy exhibited an obviously increased usage rate from 1975 to 2016, representing a mainstream treatment modality.
format Online
Article
Text
id pubmed-8033355
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-80333552021-04-09 Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis Chen, Enni Wu, Jiawei Liu, Zhiqiao Yang, Shanshan Wu, Jiali Ouyang, Puyun Xie, Fangyun Ann Transl Med Original Article BACKGROUND: Head and neck mucosal melanoma (HNMM) is defined as a rare malignant tumor derived from melanocytes. There is no consensus regarding the treatment protocol for HNMM in elderly patients. METHODS: The National Cancer Institute’s Surveillance, Epidemiology, and End Results database was used to identify elderly patients diagnosed with HNMM from 1975 to 2016. The chi-squared test was used to compare patient characteristics. The reverse Kaplan-Meier method was used to estimate the median follow-up time. The Kaplan-Meier method and log-rank test were used to estimate and compare the overall survival (OS) and disease-specific survival (DSS) of the groups. Cox regression analysis was used to evaluate the risk factors for OS and DSS of HNMM. RESULTS: Our retrospective study included 828 elderly patients with HNMM, and the 5-year OS and DSS rates were 22.4% and 27.4%, respectively. After adjusting for other variables in multivariate analysis, patients undergoing radiotherapy alone had worse OS [hazard ratio (HR) =1.449, 95% confidence interval (CI): 1.010–1.742, P=0.006] and DSS (HR =1.656, 95% CI: 1.257–2.181, P<0.001) than those undergoing surgery alone. No significant difference in OS (HR =0.892, 95% CI: 0.753–1.056, P=0.183) or DSS (HR =0.917, 95% CI: 0.764–1.101, P=0.354) was observed for patients undergoing surgery with or without radiotherapy. Our analysis of the subgroup of patients with complete clinical staging information demonstrated that the effects of surgery alone on OS (HR =0.734, 95% CI: 0.562–0.958, P=0.023) were inferior to those of surgery with radiotherapy, but no significant difference was noted compared with radiotherapy alone. CONCLUSIONS: The survival of elderly patients with HNMM is increased with the combination of surgery and radiotherapy compared with surgery alone and radiotherapy alone. In addition, the population-based analysis demonstrated that combination therapy exhibited an obviously increased usage rate from 1975 to 2016, representing a mainstream treatment modality. AME Publishing Company 2021-03 /pmc/articles/PMC8033355/ /pubmed/33842612 http://dx.doi.org/10.21037/atm-20-6021 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Chen, Enni
Wu, Jiawei
Liu, Zhiqiao
Yang, Shanshan
Wu, Jiali
Ouyang, Puyun
Xie, Fangyun
Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis
title Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis
title_full Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis
title_fullStr Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis
title_full_unstemmed Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis
title_short Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis
title_sort prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033355/
https://www.ncbi.nlm.nih.gov/pubmed/33842612
http://dx.doi.org/10.21037/atm-20-6021
work_keys_str_mv AT chenenni prognosticvaluesoftreatmentmodalitiesonheadandneckmucosalmelanomasinelderlypatientsapopulationbasedanalysis
AT wujiawei prognosticvaluesoftreatmentmodalitiesonheadandneckmucosalmelanomasinelderlypatientsapopulationbasedanalysis
AT liuzhiqiao prognosticvaluesoftreatmentmodalitiesonheadandneckmucosalmelanomasinelderlypatientsapopulationbasedanalysis
AT yangshanshan prognosticvaluesoftreatmentmodalitiesonheadandneckmucosalmelanomasinelderlypatientsapopulationbasedanalysis
AT wujiali prognosticvaluesoftreatmentmodalitiesonheadandneckmucosalmelanomasinelderlypatientsapopulationbasedanalysis
AT ouyangpuyun prognosticvaluesoftreatmentmodalitiesonheadandneckmucosalmelanomasinelderlypatientsapopulationbasedanalysis
AT xiefangyun prognosticvaluesoftreatmentmodalitiesonheadandneckmucosalmelanomasinelderlypatientsapopulationbasedanalysis